QuidelOrtho Corporation
QDELQuidelOrtho is a global provider of in vitro diagnostics, specializing in immunoassay and molecular testing, clinical chemistry, and transfusion medicine.
Earnings
Next report
Aug 6, 2026 (In 1 week)Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
QuidelOrtho is a global provider of in vitro diagnostics, specializing in immunoassay and molecular testing, clinical chemistry, and transfusion medicine. The company delivers diagnostic solutions across the continuum of care, from high-throughput hospital laboratories to point-of-care settings and over-the-counter consumer use. Its core value proposition centers on providing rapid, accurate diagnostic results that improve clinical outcomes and operational efficiency for healthcare providers in over 140 countries.
A leading global provider of in vitro diagnostics with a dominant position in point-of-care rapid testing and a significant footprint in automated transfusion medicine.
Questions, answered.
- What is QuidelOrtho Corporation's market cap?
- QuidelOrtho Corporation (QDEL) has a market capitalization of $1.1B and trades on NASDAQ.
- What is QuidelOrtho Corporation's revenue and profitability?
- QuidelOrtho Corporation generated $2.7B in trailing twelve-month revenue with a net loss of $1.2B, representing a net margin of -45.6%. Gross margin stands at 45.0%, with free cash flow of -$236.6M. These figures are based on the Q2 2026 filing.
- Who are QuidelOrtho Corporation's competitors?
- QuidelOrtho Corporation's key competitors include Bio-Rad Laboratories, Danaher Corporation, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
- Who does QuidelOrtho Corporation partner with?
- QuidelOrtho Corporation's notable partners include Aquant.
- What subsidiaries does QuidelOrtho Corporation have?
- QuidelOrtho Corporation's subsidiaries include Ortho Clinical Diagnostics.
- Where is QuidelOrtho Corporation headquartered?
- QuidelOrtho Corporation is headquartered in United States of America and employs approximately 7,100 people. It has been publicly traded since 1981.
